Sandler Laura Lee sold ORKA
May 1, 2026 · Form 4 insider transaction
Sandler Laura Lee sold 200 shares of Oruka Therapeutics, Inc. at $67.16 per share, a transaction worth $13.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
200
Price
$67.16
Total value
$13.4K
InsiderSandler Laura Lee
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 1, 2026
Filing dateMay 1, 2026
Shares owned after237,084
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.11 to $67.20, inclusive.